SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

ASL/ALT Ratio in Familial and Sporadic Parkinson's Disease: Insights From Cross-Sectional Logistic Analysis.

Brain Behav · 2026-04-01

DOI: 10.1002/brb3.71416PMID: 42021494

Open accessresearch-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

BackgroundParkinson's disease (PD) exhibits genetic heterogeneity with varying clinical presentations. The aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio has emerged as a potential indicator of neurodegenerative processes, yet its relationship with PD genetic subtypes remains unexplored.ObjectiveThis study aims to investigate the relationship between the AST to ALT ratio (AST/ALT) and different genetic subtypes of PD.MethodsThis retrospective analysis included 1315 PD patients (1005 sporadic, 310 familial) from Parkinson's Progression Markers Initiative (PPMI) databases. Multivariable logistic regression models, restricted cubic splines, and inflection point analysis were employed to assess the relationship between the AST/ALT ratio and genetic subtypes of PD, adjusting for demographic, clinical, and biochemical covariates. Subgroup and sensitivity analyses were conducted to evaluate robustness, and a predictive model was developed using stepwise selection.ResultsCompared with sporadic PD (adjusted odds ratio [OR] 1.69, 95% confidence interval 1.19-2.39, p = 0.003). A nonlinear relationship was identified (nonlinearity p = 0.002), with an inflection point at 1.503. Above this threshold, the association became markedly stronger (OR 22.27, p = 0.0007), whereas no significant association was detected below it. Findings remained consistent across all subgroup and sensitivity analyses. A predictive model incorporating the AST/ALT ratio, along with clinical and demographic factors, achieved a moderate discriminatory ability (area under the curve 0.758).ConclusionsThe AST/ALT ratio demonstrates a significant, nonlinear association with genetic subtypes of PD, particularly among individuals with higher ratio values. This readily accessible serum marker may hold promise for refining PD subtyping and informing personalized management strategies, warranting validation in prospective and diverse cohorts.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.